AU594954B2 - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds Download PDF

Info

Publication number
AU594954B2
AU594954B2 AU57637/86A AU5763786A AU594954B2 AU 594954 B2 AU594954 B2 AU 594954B2 AU 57637/86 A AU57637/86 A AU 57637/86A AU 5763786 A AU5763786 A AU 5763786A AU 594954 B2 AU594954 B2 AU 594954B2
Authority
AU
Australia
Prior art keywords
compound
formula
atoms
denotes
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU57637/86A
Other languages
English (en)
Other versions
AU5763786A (en
Inventor
Laszlo Revesz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU5763786A publication Critical patent/AU5763786A/en
Application granted granted Critical
Publication of AU594954B2 publication Critical patent/AU594954B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU57637/86A 1985-05-23 1986-05-21 Improvements in or relating to organic compounds Expired - Fee Related AU594954B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3518525 1985-05-23
DE3518525 1985-05-23

Publications (2)

Publication Number Publication Date
AU5763786A AU5763786A (en) 1986-11-27
AU594954B2 true AU594954B2 (en) 1990-03-22

Family

ID=6271435

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57637/86A Expired - Fee Related AU594954B2 (en) 1985-05-23 1986-05-21 Improvements in or relating to organic compounds

Country Status (18)

Country Link
JP (1) JPS61271275A (fr)
AU (1) AU594954B2 (fr)
BE (1) BE904796A (fr)
DK (1) DK240386A (fr)
ES (1) ES8802318A1 (fr)
FI (1) FI862124A (fr)
FR (1) FR2582309B1 (fr)
GB (1) GB2175898B (fr)
GR (1) GR861318B (fr)
HU (1) HU196376B (fr)
IL (1) IL78872A0 (fr)
IT (1) IT1203791B (fr)
LU (1) LU86435A1 (fr)
NL (1) NL8601188A (fr)
NZ (1) NZ216250A (fr)
PH (1) PH23341A (fr)
SE (1) SE8602308L (fr)
ZA (1) ZA863873B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4863928A (en) * 1989-01-04 1989-09-05 Baker Cummins Pharmaceuticals, Inc. Method of treatment for arthritic and inflammatory diseases
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
JP2906654B2 (ja) * 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
NZ246687A (en) * 1992-01-23 1996-12-20 Toray Industries Morphinan derivative and pharmaceutical compositions thereof
EP0661283B1 (fr) * 1993-07-19 1998-10-21 Toray Industries, Inc. Agent de protection de cellules cerebrales
CA2143864C (fr) * 1993-07-23 2006-01-24 Hiroshi Nagase Derives de la morphine et leurs utilisations pharmaceutiques
AR005423A1 (es) * 1996-01-10 1999-06-23 Smithkline Beecham Spa Derivados morfinoides condensados con heterociclos (ii), su uso como sustancia terapeutica y para preparar medicamentos, composiciones farmaceuticasque los contienen y procedimiento para preparar dichos derivados.
ATE291429T1 (de) * 1996-11-25 2005-04-15 Toray Industries Mittel gegen juckreiz
AU6117298A (en) * 1997-07-25 1999-02-16 Toray Industries, Inc. Hyponatremia remedies
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2987788A1 (fr) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Composés opioïdes et de type opioïde et leurs utilisations
JP4957489B2 (ja) * 2002-10-09 2012-06-20 東レ株式会社 含窒素環状置換基を有するモルヒナン誘導体またはその薬理学的に許容される酸付加塩を含有する医薬
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP2011512360A (ja) * 2008-02-14 2011-04-21 アルカーメス，インコーポレイテッド 選択的オピオイド化合物
CA2894963A1 (fr) * 2012-12-14 2014-06-19 Purdue Pharma L.P. Analogues de pyridonemorphinane et activite biologique sur des recepteurs des opioides
ES2621305T3 (es) * 2012-12-14 2017-07-03 Purdue Pharma Lp Morfinanos espirocíclicos y su uso
AR096851A1 (es) * 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
CA2951697A1 (fr) * 2014-06-13 2015-12-17 Purdue Pharma L.P. Derives d'azamophinan et leur utilisation

Also Published As

Publication number Publication date
HUT41737A (en) 1987-05-28
IT8648050A0 (it) 1986-05-23
ES8802318A1 (es) 1988-05-01
HU196376B (en) 1988-11-28
DK240386D0 (da) 1986-05-22
ES555200A0 (es) 1988-05-01
NL8601188A (nl) 1986-12-16
SE8602308D0 (sv) 1986-05-21
FR2582309B1 (fr) 1989-08-18
IL78872A0 (en) 1986-09-30
FI862124A0 (fi) 1986-05-21
GB2175898B (en) 1989-07-05
BE904796A (fr) 1986-11-21
GR861318B (en) 1986-09-19
JPS61271275A (ja) 1986-12-01
AU5763786A (en) 1986-11-27
SE8602308L (sv) 1986-11-24
PH23341A (en) 1989-07-14
GB8612159D0 (en) 1986-06-25
GB2175898A (en) 1986-12-10
NZ216250A (en) 1990-04-26
FR2582309A1 (fr) 1986-11-28
DK240386A (da) 1986-11-24
FI862124A (fi) 1986-11-24
IT1203791B (it) 1989-02-23
ZA863873B (en) 1988-01-27
LU86435A1 (fr) 1986-12-05

Similar Documents

Publication Publication Date Title
AU594954B2 (en) Improvements in or relating to organic compounds
US4912114A (en) Morphinan derivatives
US4613668A (en) Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
GB2145416A (en) Benzoic acid derivatives
US3299072A (en) Thebaine derivatives
US4374139A (en) Levorotatory N-substituted acylmorphinans useful as analgesic agents
US3639407A (en) Novel 1 2 3 4 5 6-hexahydro-6-phenyl-2 6-methano-3-benzazocines
NZ199162A (en) 8-(3-arylpropyl)-3-phenylnortropan-3-ols
US4291036A (en) Pyrido[1,2-A]pyrimidine derivatives and method of analgesic treatment
PL114723B1 (en) Proces for preparing novel derivatives of morphine
ITTO970444A1 (it) Analoghi di buprenorfina aventi proprieta' analgesiche.
EP0028717B1 (fr) Dérivés de 6,7-benzomorphane, procédés pour leur préparation, compositions pharmaceutiques contenant lesdits dérivés et leur utilisation comme médicaments
EP0361791A2 (fr) Composés azacycliques, utiles commes médicaments
PL113628B1 (en) Process for preparing novel,substituted in position 11 5,11-dihydro-6h-pyrido/2,3-b//1,4/benzodiazepin-6-ones
US3513169A (en) 5,9-diethyl benzomorphan derivatives
US2959594A (en) Iso-benzmorphan derivatives
US4390699A (en) 6-Keto-morphinans belonging to the 14-hydroxy-series
EP0233049A1 (fr) Hexahydro-2,3,4,8,9,9a aryl-4 1H-indéno[1,7-cd]azépines
EP0657455A1 (fr) Dérivés d'épi-épibatidine, un procédé et intermédiares pour leur préparation et épi-épibatidine et médicaments contenant les dérivés d'épi-épibatidine et/ou épi-épibatidine et leur utilisation
US4707484A (en) Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
CZ410691A3 (en) N-(2-methoxyethyl)-noroxymerphone, process of its preparation and pharmaceutical compositions containing it
EP0004960B1 (fr) Dérivés de 9.9-diméthyl-6.7-benzomorphane, procédés pour leur préparation et compositions pharmaceutiques les contenant
US3314964A (en) Trans indolomorphinans and process for their production
AU622506B2 (en) Novel derivatives of 1,7-(imidazo-(1,2-a)pyridine)5'-6'h) ones
PL108916B1 (en) Method of producing new derivatives of trans-5a-arylodecahydrobenzazepine